|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 显示文摘 | Avet H Facon T Grosbois B | 2002 | Cancer Genet Cytogent2002，132，1： | 1 |
| 2 | A molecular phylogeography approach to biological invasions of the New World by parthenogenetic Thiarid snails 显示文摘 | FACON B POINTIER J P GLAUBRECHT M | 2003 | Molecular Ecology2003，12，11： | 1 |
| 3 | Molecular cloning of an Echinococcus granulosus protein expressing an immunogenic epitope of antigen 5显示文摘 | Facon B Chamekh M Dissous C | 1991 | Mol Biochem Parasitol1991，45，2： | 1 |
| 4 | Tolerance of young pigs for dietary vitamin A and β-carotene, with special reference to the immune response显示文摘 | Blair R Facon M Owen B D | 1996 | Canadian Journal of Animal Science1996，76，1： | 1 |
| 5 | Oncogenesis of multiple myeloma: 1432 and 13q chromosomal abnormalities are not randomly distributed,but correlate with natural history, immunological features,and clinical presentation显示文摘 | Facon T Grosbois B | 2002 | Blood2002，99，6： | 1 |
| 6 | Thalidomide in patients with advanced multiple myeloma 显示文摘 | Moreau P Leyvraz S Berthou C Payen C Dumontet C Grosbois B Beris P Duguet C Attal M Harousseau JL Facon T | 2000 | Hematol J2000，1，3： | 1 |
| 7 | Efficacy of melphalan and predni- sone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01 /01 trial 显示文摘 | Hulin C Facon T Rodon P Pegourie B Benboubker L Doyen C Dib M Guillerm G SalIes B Esehard JP Lenain P Casas- sus P Azais I Decaux O Garderet L Mathiot C Fontan J Lafon I Virion JM Moreau P | 2009 | J Clin On- col2009，27，22： | 1 |
| 8 | Dexamethasone - based regimens veisus melphalan - prednisone for elderly multiple myeloma patients ineligible for high-dose therapy 显示文摘 | Facon T Mary JY Pegourie B | 2006 | Blood2006，107，： | 1 |
| 9 | Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation 显示文摘 | Avet-Loiseau H Facon T Grosbois B | 2002 | Blood2002，99，6： | 1 |
| 10 | Oncogenesis of multipte myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed,but correlate with natural history immunological features, and clinical presentation 显示文摘 | Avet-Loiseau H Facon T Grosbois B | 2002 | Blood2002，99，6： | 1 |
| 11 | Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history,immunological features, and clinical presentation 显示文摘 | Avet-Loiseau H Facon T Grosbois B | 2002 | Blood2002，99，： | 1 |
| 12 | Oncogenesis of multiple myeloma:14q32 and 13q chromosomal abnormalities are not randomly distributed,but correlate with natural history,immunological features,and clinical presentation显示文摘 | AVET-LOISEAU H FACON T GROSBOIS B | 2002 | Blood2002，99，6： | 1 |
| 13 | Oncogenesis of multiple myeloma: 14q32 and 13q ehromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation显示文摘 | AVET-LOISEAU H FACON T GROSBOIS B | 2002 | Blood2002，99，6： | 1 |
| 14 | Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy显示文摘 | Facon T Mary JY Pegourie B | 2006 | Blood2006，107，4： | 1 |
| 15 | Oncogenesis of multiple myeloma:14q32 and 13q chromosomal abnormalities are not randomly distributed,but correlate with natural history,immunological features,and clinical presentation显示文摘 | Avet-Loiseau H Facon T Grosbois B | 2002 | Blood2002，99，6： | 1 |
| 16 | Dexamethasone-based re- gi-mens versus melphalan-prednisone for elderly muhiple myelo- ma patients ineligible for high-dose therapy显示文摘 | Facon T Mary JY Pegourle B | 2006 | Blood2006，107，4： | 1 |
| 17 | Dexamethasone - based regimens versus melphalan - prednisone for elderly multiple myeloma patients ineligible for high - dose therapy 显示文摘 | Facon T Mary JY Pegourie B | 2006 | Blood2006，107，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员